Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Planegg/Martinsried, Germany, April 30, 2026 – Die Leo International Precision Health AG („LIPH” oder „die Gesellschaft”, Börsenkürzel: LEOW), eine Holdinggesellschaft, die ein globales, integriertes...
-
Planegg/Martinsried, Germany, April 30, 2026 – Leo International Precision Health AG (“LIPH” or the “Company”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare...
-
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
-
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the first quarter 2026...
-
Wearable healthcare devices market size is projected to reach USD 137.40 billion by 2034 from its value of USD 47.53 billion in 2024, at a CAGR of 11.20%
-
BaaS in healthcare market size is projected to hit $ 3,609.31 MN by 2034 from its value of $ 545.45 MN in 2024, at a CAGR of 20.80% from 2025 to 2034
-
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
-
NACO hosts an embargoed media briefing May 1 on Canada's Top Moonshot Ventures™ of 2026 ahead of their public announcement at NACO Summit in Ottawa.
-
Aclarion Announces $2.5 Million Stock Repurchase Plan
-
MONTRÉAL, April 21, 2026 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a leading Canadian Healthtech company, announces today that...